NPPA: Retail prices of 40 formulations fixed
The National Pharmaceutical Pricing Authority (NPPA) has fixed prices for 40 different formulations produced by 12 manufacturers which applied for the same by submitting Form-I for price fixation/revision as stipulated…
DCGI granted nod to SunPharma for clinical trial with Nafamostat
The Drugs Controller General of India (DCGI) gave green signal to Sun Pharmaceutical Industries to conduct clinical trial with Nafamostat Mesilate for the treatment of COVID-19 patients. Nafamostat has been…
NPPA: Cipla to improve the supply of tocilizumab injection
The pharmaceutical major Cipla Ltd has been directed by the National Pharmaceutical Pricing Authority (NPPA) to improve the supply and demand of tocilizumab injection in Gujarat useful in treatment of…
NPPA: Manufacturers of N-95 masks directed to maintain parity in prices for non-govt procurements to curb black marketing
Manufacturers, importers and suppliers of N-95 has been directed by the National Pharmaceutical Pricing Authority (NPPA) for maintaining parity in prices for non-government procurements for the purpose of making available…
DoP proposes to oversee drug regulator
As the government plans a major overhaul of the country’s drug authority, the Department of Pharmaceuticals (DoP) has proposed to oversee Central Drugs Standard Control Organisation (CDSCO) to be transferred…
COVID-19: DCGI approved NovaLead Pharma to conduct clinical
The Drugs Controller General of India (DCGI) has granted approval to NovaLead Pharma for conducting of phase III clinical trials for its repurposed drug discovery for treatemnt of moderate COVID-19…
CDSCO observed shortage of 15 drugs
A letter has been issued by the Central Drugs Standard Control Organisation (CDSCO) to all drug manufacturers associations giving an information about the low supply of 15 essential drugs which…
Nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease approved by DCGI
May 20, 2020: Drugs Controller General of India (DCGI) has approved Nintedanib by Boehringer Ingelheim (India) in treating systemic sclerosis-associated interstitial lung disease (SSc-ILD) in adults. Earlier on 3rd March,…
59 product licenses to 37 new comapines to manufacture azithromycin approved by Gujarat FDCA
The Gujarat Food and Drug Control Administration (FDCA) has approved 59 product licenses to 37 manufacturers for production of azithromycin as a basic treatment for Covid-19 patients. Hydroxychloroquine (HCQ) in…
CDSCO lifted export restrictions on paracetamol APIs
A letter has been issued by the Central Drugs Standard Control Organisation (CDSCO to all the State and Union Territories Drug Controllers with a recommendations to revoke export restrictions on…
